The Nebulizer Devices Market is estimated to witness stupendous growth in the years to come. AI is already into the disruption mode regarding the healthcare vertical. Machine learning is used for displaying the relevant info about health in the mobile app. The application of AI in healthcare is better known as “Augmented Intelligence”. This would be the running trend in the healthcare vertical in the upcoming period.
Persistence Market Research (PMR) has recently published a research report titled “Nebulizer Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” The report states that the global nebulizer devices market is expected to witness a stable growth in the coming years. Advances in healthcare and the introduction of new drugs has been anticipated to trigger the adoption of nebulizer devices until 2025 end, thus supporting the overall growth of the market.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22411
On these grounds, the global nebulizer devices market is expected to expand at 6.6% CAGR from 2017 to 2025. The market is projected to rise to a valuation of over US$ 3,382 Mn by the end of 2025 from a valuation of around US$ 2,033 Mn in 2017.
- Agilent Technologies, Inc.
- Allied Healthcare Products, Inc.
- CareFusion Corporation (sub. Becton, Dickinson and Company)
- Covidien plc (sub. Medtronic)
- GE Healthcare
- GF Health Products Inc.
- Omron Healthcare, Inc.
- PARI GmbH
- Koninklijke Philips N.V.
Get A Customized Scope To Match Your Need Ask An Expert – firstname.lastname@example.org
High prevalence of cystic fibrosis and COPD has been witnessed significantly across the globe. However, the exact cause for asthma and cystic fibrosis is still unknown, but some of the risk factors include hereditary conditions and environmental pollution that lead to chemical irritation. On the other hand, COPD mostly occurs due to cigarette smoking. The American Academy of Allergy Asthma and Immunology stated in 2012 that over 100 million people would suffer from asthma across the world by the end of 2025.
Numerous awareness programs have been initiated by healthcare providers and health organizations and societies across the globe in the form of environmental programs, medication maintenance programs, and online education programs for public and healthcare professionals across the globe to control COPD, asthma, and other respiratory diseases. In this case, healthcare organizations and providers are teaming up to prevent respiratory diseases and improve the condition of the patients by providing them with better services and facilities. AstraZeneca is collaborating with 10 other market giants to prevent and control the spread of respiratory diseases in China. The use of nebulizer devices is expected to increase in the coming years, owing to the increasing instances of chronic diseases across the globe.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/22411
Implementation of Strict Regulations and Drug Loss During Delivery to Hinder Market Progress
Nebulizers are efficient and effective in drug delivery; nevertheless, the prime factor associated with these devices is the loss of the drug during delivery. Pneumatic nebulizers have been foreseen to lose some amount of the drug in the spray chamber during delivery. Ultrasonic nebulizers incorporate the use of ultrasonic waves, which escalates the chances of drug inactivation during delivery. Moreover, ultrasonic waves are harmful to the human body. This factor may negatively impact the growth of the ultrasonic nebulizer devices market. Also, governments across the globe have imposed strict regulations on the approval of nebulizer devices.
So, despite several awareness programs and technological advancements paving the way for a better future for the market, will the sales of nebulizer devices garner sufficient revenue in the long run; and will the market stay unaffected by the regulations imposed is something that remains to be seen.
Read More Trending “PMR Exclusive Article”-
Dermatophytic Onychomycosis Therapeutics Market–Dermatophytic Onychomycosis Therapeutics Market Segmented By Tablets and Nail Paints Product in Oral, Topical Treatment in Hospitals, Clinics, Independent Pharmacies, Mail Order Pharmacies, Drug Stores
Insomnia Treatment Market–Insomnia Treatment Market Segmented By OTC drugs and Prescription Drugs in Hospital Pharmacies, Retail Pharmacies, E-commerce and Drug Stores, hypermarkets
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com
Website – https://www.persistencemarketresearch.com
Why pay for news and opinions when you can get them for free?
Subscribe for free now!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
BUSINESS3 days ago
Lifetime relationships and employee loyalty: How the total experience approach is transforming insurance
BUSINESS3 days ago
The future of B2B marketplace payments and B2B Buy Now, Pay Later
BUSINESS3 days ago
BNPL for Services: Unlocking business growth with tailored payment solutions for the service industry
FINANCE3 days ago
Top financial advisor firms